Pages that link to "Q37479419"

The following pages link to Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept (Q37479419):

Displaying 38 items.

• Pramlintide for diabetes mellitus (Q24186857) (← links)
• Pramlintide for diabetes mellitus (Q24240172) (← links)
• Psychological aspects of diabetes care: Effecting behavioral change in patients (Q27003454) (← links)
• Pituitary Adenlylate Cyclase Activating Peptide Protects Adult Neural Stem Cells from a Hypoglycaemic milieu (Q27341805) (← links)
• Initiation and Intensification Strategies in Type 2 Diabetes Management: A Comparison of Basal Plus and Premix Regimens (Q28077688) (← links)
• 28-week, randomized, multicenter, open-label, parallel-group phase III trial to investigate the efficacy and safety of biphasic insulin aspart 70 thrice-daily injections vs twice-daily injections of biphasic insulin aspart 30 in patients with type 2 (Q33558430) (← links)
• Impact of postprandial hyperglycemia at clinic visits on the incidence of cardiovascular events and all-cause mortality in patients with type 2 diabetes (Q33871377) (← links)
• Single-nucleotide polymorphisms in chromosome 3p14.1- 3p14.2 are associated with susceptibility of type 2 diabetes with cataract (Q33980583) (← links)
• The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c (Q34748572) (← links)
• Comparing the disease profiles of adult patients with type 2 diabetes mellitus attending four public health care facilities in Malaysia (Q35454400) (← links)
• Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month 'proof-of-concept' study. (Q35589774) (← links)
• Hypoglycemia, diabetes, and cardiovascular disease (Q35990856) (← links)
• Hyperglycemia in-hospital management (Q36327988) (← links)
• Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring (Q36473734) (← links)
• Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus (Q36568360) (← links)
• Evaluation of the Effect of Carbohydrate Intake on Postprandial Glucose in Patients With Type 1 Diabetes Treated With Insulin Pumps (Q37391381) (← links)
• Cerebral ischemic damage in diabetes: an inflammatory perspective (Q37602716) (← links)
• Impact of glycemic variability on cardiovascular outcomes beyond glycated hemoglobin. Evidence and clinical perspectives. (Q38016729) (← links)
• How can we monitor glycaemic variability in the clinical setting? (Q38137388) (← links)
• Effects of Acarbose Versus Glibenclamide on Glycemic Excursion and Oxidative Stress in Type 2 Diabetic Patients Inadequately Controlled by Metformin: A 24-Week, Randomized, Open-Label, Parallel-Group Comparison (Q38481319) (← links)
• Antioxidant properties of drugs used in Type 2 diabetes management: could they contribute to, confound or conceal effects of antioxidant therapy? (Q38780360) (← links)
• The impact of glycemic variability on diabetic peripheral neuropathy (Q38887664) (← links)
• The association of long-term glycaemic variability versus sustained chronic hyperglycaemia with heart rate-corrected QT interval in patients with type 2 diabetes (Q41533654) (← links)
• Glycemic variability: can we bridge the divide between controversies? (Q42703555) (← links)
• International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, Greece (Q42730182) (← links)
• Assessment of glycemic control: new insights into the evaluation of the diabetic patient (Q42745518) (← links)
• Longitudinal dynamics of body weight change in the development of type 2 diabetes (Q44598596) (← links)
• Pentads and Hexads in Diabetes Care: Numbers as Targets; Numbers as Tools (Q47122631) (← links)
• Association of glycaemic variability evaluated by continuous glucose monitoring with diabetic peripheral neuropathy in type 2 diabetic patients. (Q48092476) (← links)
• Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring (Q48932220) (← links)
• High-normal serum thyrotropin levels and increased glycemic variability in type 2 diabetic patients. (Q52590576) (← links)
• Comparison of glucose variability assessed by a continuous glucose-monitoring system in patients with type 2 diabetes mellitus switched from NPH insulin to insulin glargine: the COBIN2 study. (Q53094708) (← links)
• Nerve conduction study of the association between glycemic variability and diabetes neuropathy (Q58748422) (← links)
• Continuous Glucose Monitoring Reveals Abnormal Features of Postprandial Glycemic Excursions in Women with Polycystic Ovarian Syndrome (Q83809705) (← links)
• Associations of serum glucagon levels with glycemic variability in type 1 diabetes with different disease durations (Q89146312) (← links)
• Treatment and prevention of severe hypoglycaemia in people with diabetes: Current and new formulations of glucagon (Q91837641) (← links)
• Influence of glucometric 'dynamical' variables on duodenal-jejunal bypass liner (DJBL) anthropometric and metabolic outcomes (Q92511565) (← links)
• Association between breakfast skipping and postprandial hyperglycaemia after lunch in healthy young individuals (Q93116072) (← links)